40
Participants
Start Date
July 31, 2018
Primary Completion Date
July 31, 2019
Study Completion Date
June 30, 2020
CM082 plus JS001
CM082:200mg once a day (qd) orally (taken within half an hour after breakfast). JS001 :An intravenous infusion of a solution having a concentration of 1-10 mg/ml was prepared with 0.9% physiological saline, and administered once every two weeks. Using an inline filter (0.2 or 0.22 μm), the drug was diluted with physiological saline and intravenously administered within 60 minutes.
RECRUITING
Beijing Cancer Hospital, Beijing
Lead Sponsor
AnewPharma
INDUSTRY